U.S. markets closed
  • S&P 500

    4,356.45
    -53.68 (-1.22%)
     
  • Dow 30

    34,297.73
    -66.77 (-0.19%)
     
  • Nasdaq

    13,539.29
    -315.83 (-2.28%)
     
  • Russell 2000

    2,004.03
    -29.48 (-1.45%)
     
  • Crude Oil

    85.31
    -0.29 (-0.34%)
     
  • Gold

    1,849.60
    -2.90 (-0.16%)
     
  • Silver

    23.92
    +0.03 (+0.12%)
     
  • EUR/USD

    1.1307
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.7830
    +0.0480 (+2.77%)
     
  • GBP/USD

    1.3510
    +0.0004 (+0.03%)
     
  • USD/JPY

    113.8600
    -0.0060 (-0.01%)
     
  • BTC-USD

    36,895.98
    +318.46 (+0.87%)
     
  • CMC Crypto 200

    831.82
    +11.23 (+1.37%)
     
  • FTSE 100

    7,371.46
    +74.31 (+1.02%)
     
  • Nikkei 225

    27,131.34
    0.00 (0.00%)
     

This Unstoppable Cancer-Treatment Company's Stock Is on Sale Now

·5 min read
This Unstoppable Cancer-Treatment Company's Stock Is on Sale Now
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • NVCR

Cancer treatment company Novocure (NASDAQ: NVCR), which uses low-power electrical fields to disrupt the growth of cancer cells, is now trading 50% below its highs. The company has numerous clinical trials of its technology underway, but traders sold the stock lower after its most recent quarterly earnings report came and went without fresh approvals for new indications from the U.S. Food and Drug Administration (FDA). Let's start by addressing the elephant in the room -- the company's need of new regulatory approvals for its tech to be used in treating additional types of cancers.